BOT 1.56% 31.5¢ botanix pharmaceuticals ltd

Ann: Half Yearly Report and Accounts, page-75

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 1,400 Posts.
    lightbulb Created with Sketch. 560
    FOX News on the Colorado's murder case involving Accutane, Dr Marc Siegel puts it this way:

    http://video.foxnews.com/v/5742126034001/?#sp=show-clips

    "Can aggressive behaviour be linked to Accutane? Yes...[....].....A huge public service message we can do today...[...]...I think this drug is prescribed too quickly, too easily and you should look for alternative first"

    So BTX1503 is not just more effective (as shown by the recent clinical study) that the two most widely used (in the USA) Epiduo and Aczone (with combined annual sales of $1b) but is going to disrupt a market ripe for a safe alternative to isotretinoin, the drug of 'last resort' against acne.
 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
(20min delay)
Last
31.5¢
Change
-0.005(1.56%)
Mkt cap ! $572.5M
Open High Low Value Volume
32.0¢ 32.0¢ 31.0¢ $1.366M 4.341M

Buyers (Bids)

No. Vol. Price($)
18 342765 31.0¢
 

Sellers (Offers)

Price($) Vol. No.
32.0¢ 723414 18
View Market Depth
Last trade - 16.10pm 18/11/2024 (20 minute delay) ?
BOT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.